Global Blood Screening Market Analysis 2017 - Forecast to 2025

  • ID: 4540519
  • Report
  • Region: Global
  • 148 pages
  • Hoovers Research
1 of 3
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2014 to 2025 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:
  • Market Sizing estimations and forecasts across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities,)
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Blood Screening Market by Product
5.1 Introduction
5.2 Instrument
5.3 Reagent & kits
5.3.1 ELISA Kit
5.3.2 NAT Kit
5.3.3 Other Reagent & Kits
5.4 Software & services
5.5 Standards and controls
5.6 Immunosorbents
5.7 Sample diluents and wash solutions
5.8 Probes and Primers
5.9 Substrates and Instruments
5.10 Buffers
5.11 Conjugates
5.12 Enzymes and Polymerases
5.13 Labeling and detection reagents
5.14 Nucleotides and Solutions

6 Blood Screening Market by Technology
6.1 Introduction
6.2 Western Blot Assay
6.3 Nucleic Acid Amplification Test (NAT)
6.3.1 Transcription-mediated amplification
6.3.2 Real-time polymerase chain reaction
6.4 Enzyme-linked immunosorbent assay
6.4.1 Generation
6.4.1.1 First Generation
6.4.1.2 Second Generation
6.4.1.3 Third Generation
6.4.1.4 Fourth Generation & Above
6.4.2 Platform
6.4.2.1 Chemiluminescence immunoassay
6.4.2.2 Fluorescence immunoassay
6.4.2.3 Colorimetric immunoassay
6.5 Next-Generation Sequencing (NGS)
6.6 Rapid tests

7 Blood Screening Market by Application
7.1 Introduction
7.2 Blood Disorder Blood Testing
7.3 Kidney Disorder Blood Testing
7.4 Fertility Blood Testing
7.5 Diabetes Blood Testing
7.6 Liver Disorder Blood Testing
7.7 Cancer Blood Testing
7.8 Pregnancy Blood Testing
7.9 Home-Monitoring Blood Testing
7.10 Cardiovascular Disease Blood Testing
7.11 Autoimmune Disease And Food Allergy Testing

8 Blood Screening Market by End user
8.1 Introduction
8.2 Hospitals
8.3 Blood banks

9 Geographical Segmentation
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 South America
9.4.1 Argentina
9.4.2 Brazil
9.4.3 Venezuela
9.4.4 Chile
9.4.5 Peru
9.5 Middle East & Africa
9.5.1 UAE
9.5.2 Saudi Arabia
9.5.3 Qatar
9.5.4 Iran
9.5.5 South Africa
9.5.6 Rest of MEA

10 Vendor Landscaping
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiles
11.1 Danaher Corporation (Beckman Coulter)
11.1.1 Business Overview
11.1.2 SWOT Analysis
11.1.3 Financial Overview
11.1.4 Strategy
11.1.5 Key Activities
11.2 Bio-Rad Laboratories, Inc.
11.3 Abbott Laboratories
11.4 Thermo Fisher Scientific, Inc
11.5 SOFINA s.a (Biomérieux)
11.6 Grifols, S.A.
11.7 Becton Dickinson and Company
11.8 F. Hoffmann-La Roche AG
11.9 Ortho-Clinical Diagnostics, Inc.
11.10 Siemens Healthcare GmbH
11.11 Roche Diagnostics
11.12 Beckman Coulter, Inc.
11.13 Apex Biotechnology Corp.
11.14 Alere Inc.
11.15 Luminex Corp
11.16 Trinity Biotech

12 Appendix

13 Disclaimer

List of Tables
Table 1 Global Blood Screening Market Analysis, by Region, (2017-2025) ($MN)
Table 2 Global Blood Screening Market Analysis, by Product, (2017-2025) ($MN)
Table 3 Global Blood Screening Market Analysis, by Instrument, (2017-2025) ($MN)
Table 4 Global Blood Screening Market Analysis, by Reagent & kits, (2017-2025) ($MN)
Table 5 Global Blood Screening Market Analysis, by ELISA Kit, (2017-2025) ($MN)
Table 6 Global Blood Screening Market Analysis, by NAT Kit, (2017-2025) ($MN)
Table 7 Global Blood Screening Market Analysis, by Other Reagent & Kits, (2017-2025) ($MN)
Table 8 Global Blood Screening Market Analysis, by Software & services, (2017-2025) ($MN)
Table 9 Global Blood Screening Market Analysis, by Standards and controls, (2017-2025) ($MN)
Table 10 Global Blood Screening Market Analysis, by Immunosorbents, (2017-2025) ($MN)
Table 11 Global Blood Screening Market Analysis, by Sample diluents and wash solutions, (2017-2025) ($MN)
Table 12 Global Blood Screening Market Analysis, by Probes and Primers, (2017-2025) ($MN)
Table 13 Global Blood Screening Market Analysis, by Substrates and Instruments, (2017-2025) ($MN)
Table 14 Global Blood Screening Market Analysis, by Buffers, (2017-2025) ($MN)
Table 15 Global Blood Screening Market Analysis, by Conjugates, (2017-2025) ($MN)
Table 16 Global Blood Screening Market Analysis, by Enzymes and Polymerases, (2017-2025) ($MN)
Table 17 Global Blood Screening Market Analysis, by Labeling and detection reagents, (2017-2025) ($MN)
Table 18 Global Blood Screening Market Analysis, by Nucleotides and Solutions, (2017-2025) ($MN)
Table 19 Global Blood Screening Market Analysis, by Technology, (2017-2025) ($MN)
Table 20 Global Blood Screening Market Analysis, by Western Blot Assay, (2017-2025) ($MN)
Table 21 Global Blood Screening Market Analysis, by Nucleic Acid Amplification Test (NAT), (2017-2025) ($MN)
Table 22 Global Blood Screening Market Analysis, by Transcription-mediated amplification, (2017-2025) ($MN)
Table 23 Global Blood Screening Market Analysis, by Real-time polymerase chain reaction, (2017-2025) ($MN)
Table 24 Global Blood Screening Market Analysis, by Enzyme-linked immunosorbent assay, (2017-2025) ($MN)
Table 25 Global Blood Screening Market Analysis, by Generation, (2017-2025) ($MN)
Table 26 Global Blood Screening Market Analysis, by Platform, (2017-2025) ($MN)
Table 27 Global Blood Screening Market Analysis, by Next-Generation Sequencing (NGS), (2017-2025) ($MN)
Table 28 Global Blood Screening Market Analysis, by Rapid tests, (2017-2025) ($MN)
Table 29 Global Blood Screening Market Analysis, by Application, (2017-2025) ($MN)
Table 30 Global Blood Screening Market Analysis, by Blood Disorder Blood Testing, (2017-2025) ($MN)
Table 31 Global Blood Screening Market Analysis, by Kidney Disorder Blood Testing, (2017-2025) ($MN)
Table 32 Global Blood Screening Market Analysis, by Fertility Blood Testing, (2017-2025) ($MN)
Table 33 Global Blood Screening Market Analysis, by Diabetes Blood Testing, (2017-2025) ($MN)
Table 34 Global Blood Screening Market Analysis, by Liver Disorder Blood Testing, (2017-2025) ($MN)
Table 35 Global Blood Screening Market Analysis, by Cancer Blood Testing, (2017-2025) ($MN)
Table 36 Global Blood Screening Market Analysis, by Pregnancy Blood Testing, (2017-2025) ($MN)
Table 37 Global Blood Screening Market Analysis, by Home-Monitoring Blood Testing, (2017-2025) ($MN)
Table 38 Global Blood Screening Market Analysis, by Cardiovascular Disease Blood Testing, (2017-2025) ($MN)
Table 39 Global Blood Screening Market Analysis, by Autoimmune Disease And Food Allergy Testing, (2017-2025) ($MN)
Table 40 Global Blood Screening Market Analysis, by End user, (2017-2025) ($MN)
Table 41 Global Blood Screening Market Analysis, by Hospitals, (2017-2025) ($MN)
Table 42 Global Blood Screening Market Analysis, by Blood banks, (2017-2025) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll